From neutrophils to macrophages: Differences in regional adipose tissue depots

Obesity Reviews

Volumn 17, Issue 1, 2016, Pages 1-17

  Dam, V ^a   Sikder, T ^a   Santosa, S ^a  

^a Civil and Environmental Engineering   (Canada)

Author keywords

Adipose tissue; Immune cell; Inflammation; Obesity

Indexed keywords

ADAPTIVE IMMUNITY; ADIPOSE TISSUE; ARTICLE; B LYMPHOCYTE; CELLULAR DISTRIBUTION; COMORBIDITY; EOSINOPHIL; FLOW CYTOMETRY; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; T LYMPHOCYTE; COMPLICATION; HUMAN; IMMUNOLOGY; INSULIN RESISTANCE; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

ADAPTIVE IMMUNITY; ADIPOSE TISSUE; EOSINOPHILS; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN RESISTANCE; KILLER CELLS, NATURAL; MACROPHAGES; NEUTROPHILS; OBESITY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84958893045     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12335     Document Type: Article

References (164)

1. Halaas JL, Gajiwala KS, Maffei M et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
2. Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 2014; 222: R113-R127.
3. Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 2003; 19: 457-466.
4. Santosa S, Jensen MD. Sex and sex steroids: impact on the kinetics of fatty acids underlying body shape. Horm Mol Biol Clin Investig 2014; 20: 15-23.
5. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96: 88-98.
6. Bray GA, Jablonski KA, Fujimoto WY et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr 2008; 87: 1212-1218.
7. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46: 1579-1585.
8. Kannel WB, Cupples LA, Ramaswami R, Stokes J 3rd, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol 1991; 44: 183-190.
9. Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol 2013; 62: 921-925.
10. Pischon T, Boeing H, Hoffmann K et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105-2120.
11. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010; 11: 11-18.
12. Toyoda M, Matsubara Y, Lin K, Sugimachi K, Furue M. Characterization and comparison of adipose tissue-derived cells from human subcutaneous and omental adipose tissues. Cell Biochem Funct 2009; 27: 440-447.
13. Dettmeyer RB, SpringerLink (Online service). Staining techniques and microscopy. In: Dettmeyer RB (ed.). Forensic Histopathology Fundamentals and Perspectives1 online resource. Springer-Verlag Berlin Heidelberg: Berlin, Heidelberg, 2011.
14. Ramos-Vara JA. Technical aspects of immunohistochemistry. Vet Pathol 2005; 42: 405-426.
15. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
16. Nishimura S, Manabe I, Nagasaki M et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914-920.
17. Xu HY, Barnes GT, Yang Q et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830.
18. Valasek MA, Repa JJ. The power of real-time PCR. Adv Physiol Educ 2005; 29: 151-159.
19. Arsenijevic T, Gregoire F, Delforge V, Delporte C, Perret J. Murine 3T3-L1 adipocyte cell differentiation model: validated reference genes for qPCR gene expression analysis. PLoS One 2012; 7: e37517.
20. Greenbaum D, Colangelo C, Williams K, Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 2003; 4: 117.
21. Khazen W, M'Bika JP, Tomkiewicz C et al. Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Lett 2005; 579: 5631-5634.
22. Lee BC, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta 2014; 1842: 446-462.
23. Majka SM, Miller HL, Helm KM et al. Analysis and isolation of adipocytes by flow cytometry. Methods Enzymol 2014; 537: 281-296.
24. Wlodkowic D, Skommer J, Darzynkiewicz Z. Flow cytometry-based apoptosis detection. Methods Mol Biol 2009; 559: 19-32.
25. Cho KW, Morris DL, Lumeng CN. Flow cytometry analyses of adipose tissue macrophages. Methods Enzymol 2014; 537: 297-314.
26. Brake DK, Smith CW. Flow cytometry on the stromal-vascular fraction of white adipose tissue. Methods Mol Biol 2008; 456: 221-229.
27. Alitalo K. The lymphatic vasculature in disease. Nat Med 2011; 17: 1371-1380.
28. Harvey NL. The link between lymphatic function and adipose biology. Ann N Y Acad Sci 2008; 1131: 82-88.
29. Yokota T, Oritani K, Takahashi I et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000; 96: 1723-1732.
30. Curat CA, Miranville A, Sengenes C et al. From blood monocytes to adipose tissue-resident macrophages - induction of diapedesis by human mature adipocytes. Diabetes 2004; 53: 1285-1292.
31. Alexaki VI, Notas G, Pelekanou V et al. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development. J Immunol 2009; 183: 5948-5956.
32. Chung S, LaPoint K, Martinez K, Kennedy A, Sandberg MB, McIntosh MK. Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 2006; 147: 5340-5351.
33. Di Gregorio GB, Yao-Borengasser A, Rasouli N et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues - association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005; 54: 2305-2313.
34. Meijer K, de Vries M, Al-Lahham S et al. Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. Plos One 2011; 6: e17154.
35. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001; 60: 349-356.
36. MacQueen HA, Pond CM. Immunofluorescent localisation of tumour necrosis factor-alpha receptors on the popliteal lymph node and the surrounding adipose tissue following a simulated immune challenge. J Anat 1998; 192: 223-231.
37. Samuvel DJ, Jin JF, Sundararaj KP et al. TLR4 activation and IL-6-mediated cross talk between adipocytes and mononuclear cells synergistically stimulate MMP-1 expression. Endocrinology 2011; 152: 4662-4671.
38. Anderson EK, Gutierrez DA, Hasty AH. Adipose tissue recruitment of leukocytes. Curr Opin Lipidol 2010; 21: 172-177.
39. Neumeier M, Bauer S, Bruhl H et al. Adiponectin stimulates release of CCL2, -3, -4 and-5 while the surface abundance of CCR2 and-5 is simultaneously reduced in primary human monocytes. Cytokine 2011; 56: 573-580.
40. Creely SJ, McTernan PG, Kusminski CM et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol-Endocrinol Metab 2007; 292: E740-E747.
41. Ortega Martinez de Victoria E, Xu X, Koska J et al. Macrophage content in subcutaneous adipose tissue: associations with adiposity, age, inflammatory markers, and whole-body insulin action in healthy Pima Indians. Diabetes 2009; 58: 385-393.
42. Gordon S. The role of the macrophage in immune regulation. Res Immunol 1998; 149: 685-688.
43. Cinti S, Mitchell G, Barbatelli G et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46: 2347-2355.
44. Cancello R, Henegar C, Viguerie N et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54: 2277-2286.
45. Duffaut C, Galitzky J, Lafontan M, Bouloumie A. Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun 2009; 384: 482-485.
46. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-919.
47. Cousin S, Andre M, Casteilla L, Penicaud L. Altered macrophage-like functions of preadipocytes in inflammation and genetic obesity. J Cell Physiol 2001; 186: 380-386.
48. Rocha VZ, Folco EJ, Sukhova G et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 2008; 103: 467-476.
49. Kintscher U, Hartge M, Hess K et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008; 28: 1304-1310.
50. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010; 314: 1-16.
51. Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 2005; 29: 146-150.
52. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001; 175: 81-92.
53. Suganami T, Mieda T, Itoh M, Shimoda Y, Kamei Y, Ogawa Y. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a toll-like receptor 4 mutation. Biochem Biophys Res Commun 2007; 354: 45-49.
54. Arner P. Not all fat is alike. Lancet 1998; 351: 1301-1302.
55. Murano I, Barbatelli G, Parisani V et al. Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J Lipid Res 2008; 49: 1562-1568.
56. Okamoto Y, Higashiyama H, Rong JX et al. Comparison of mitochondrial and macrophage content between subcutaneous and visceral fat in db/db mice. Exp Mol Pathol 2007; 83: 73-83.
57. Altintas MM, Azad A, Nayer B et al. Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res 2011; 52: 480-488.
58. Wamil M, Battle JH, Turban S et al. Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2011; 60: 1158-1167.
59. Han L, Tang MX, Ti Y et al. Overexpressing STAMP2 improves insulin resistance in diabetic ApoE(-)/(-)/LDLR(-)/(-) mice via macrophage polarization shift in adipose tissues. PLoS One 2013; 8: e78903.
60. Cohen CA, Shea AA, Heffron CL, Schmelz EM, Roberts PC. Intra-abdominal fat depots represent distinct immunomodulatory microenvironments: a murine model. PLoS One 2013; 8: e66477.
61. van Beek L, van Klinken JB, Pronk AC et al. The limited storage capacity of gonadal adipose tissue directs the development of metabolic disorders in male C57Bl/6J mice. Diabetologia 2015; 58: 1601-1609.
62. Alvehus M, Buren J, Sjostrom M, Goedecke J, Olsson T. The human visceral fat depot has a unique inflammatory profile. Obesity (Silver Spring) 2010; 18: 879-883.
63. Harman-Boehm I, Bluher M, Redel H et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007; 92: 2240-2247.
64. Susleyici-Duman B, Zengin K, Kayhan FE et al. FTO mRNA expression in extremely obese and type 2 diabetic human omental and subcutaneous adipose tissues. Obes Surg 2011; 21: 1766-1773.
65. Cancello R, Tordjman J, Poitou C et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006; 55: 1554-1561.
66. van Beek L, Lips MA, Visser A et al. Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism 2014; 63: 492-501.
67. Viardot A, Lord RV, Samaras K. The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes. J Clin Endocrinol Metab 2010; 95: 2845-2850.
68. Michaud A, Drolet R, Noel S, Paris G, Tchernof A. Visceral fat accumulation is an indicator of adipose tissue macrophage infiltration in women. Metabolism 2012; 61: 689-698.
69. Klimcakova E, Roussel B, Kovacova Z et al. Macrophage gene expression is related to obesity and the metabolic syndrome in human subcutaneous fat as well as in visceral fat. Diabetologia 2011; 54: 876-887.
70. McLaughlin T, Deng A, Gonzales O et al. Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women. Diabetologia 2008; 51: 2303-2308.
71. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175-184.
72. Wentworth JM, Naselli G, Brown WA et al. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010; 59: 1648-1656.
73. Gordon S. Macrophage heterogeneity and tissue lipids. J Clin Invest 2007; 117: 89-93.
74. Dalmas E, Clement K, Guerre-Millo M. Defining macrophage phenotype and function in adipose tissue. Trends Immunol 2011; 32: 307-314.
75. Zeyda M, Stulnig TM. Adipose tissue macrophages. Immunol Lett 2007; 112: 61-67.
76. Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008; 57: 3239-3246.
77. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 2008; 8: 301-309.
78. Aron-Wisnewsky J, Tordjman J, Poitou C et al. Human adipose tissue macrophages: M1 and M2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 2009; 94: 4619-4623.
79. Samaras K, Viardot A, Lee PN et al. Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance. Diab Vasc Dis Res 2013; 10: 40-48.
80. Samaras K, Viardot A, Botelho NK, Jenkins A, Lord RV. Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery. Diabetologia 2013; 56: 2564-2572.
81. Wu D, Molofsky AB, Liang HE et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011; 332: 243-247.
82. Spencer LA, Szela CT, Perez SA et al. Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol 2009; 85: 117-123.
83. Jacobsen EA, Helmers RA, Lee JJ, Lee NA. The expanding role(s) of eosinophils in health and disease. Blood 2012; 120: 3882-3890.
84. Akuthota P, Wang H, Weller PF. Eosinophils as antigen-presenting cells in allergic upper airway disease. Curr Opin Allergy Clin Immunol 2010; 10: 14-19.
85. MacKenzie JR, Mattes J, Dent LA, Foster PS. Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function. J Immunol 2001; 167: 3146-3155.
86. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-483.
87. Ricardo-Gonzalez RR, Red Eagle A, Odegaard JI et al. IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity. Proc Natl Acad Sci U S A 2010; 107: 22617-22622.
88. Jaillon S, Galdiero MR, Del Prete D, Cassatella MA, Garlanda C, Mantovani A. Neutrophils in innate and adaptive immunity. Semin Immunopathol 2013; 35: 377-394.
89. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol 2012; 30: 459-489.
90. Soehnlein O, Zernecke A, Eriksson EE et al. Neutrophil secretion products pave the way for inflammatory monocytes. Blood 2008; 112: 1461-1471.
91. Talukdar S, Oh da Y, Bandyopadhyay G et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 2012; 18: 1407-1412.
92. Elgazar-Carmon V, Rudich A, Hadad N, Levy R. Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J Lipid Res 2008; 49: 1894-1903.
93. O'Rourke RW, Metcalf MD, White AE et al. Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue. Int J Obes (Lond) 2009; 33: 978-990.
94. Wensveen FM, Jelencic V, Valentic S et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol 2015; 16: 376-385.
95. O'Rourke RW, Gaston GD, Meyer KA, White AE, Marks DL. Adipose tissue NK cells manifest an activated phenotype in human obesity. Metabolism 2013; 62: 1557-1561.
96. Kelly JM, Takeda K, Darcy PK, Yagita H, Smyth MJ. A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo. J Immunol 2002; 168: 4472-4479.
97. Scharton TM, Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993; 178: 567-577.
98. Bellora F, Castriconi R, Dondero A et al. The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. Proc Natl Acad Sci U S A 2010; 107: 21659-21664.
99. Martin-Fontecha A, Thomsen LL, Brett S et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5: 1260-1265.
100. Brillard E, Pallandre JR, Chalmers D et al. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes. Exp Hematol 2007; 35: 416-425.
101. Goldszmid RS, Caspar P, Rivollier A et al. NK cell-derived interferon-gamma orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection. Immunity 2012; 36: 1047-1059.
102. O'Rourke RW, Meyer KA, Neeley CK et al. Systemic NK cell ablation attenuates intra-abdominal adipose tissue macrophage infiltration in murine obesity. Obesity (Silver Spring) 2014; 22: 2109-2114.
103. O'Rourke RW, White AE, Metcalf MD et al. Systemic inflammation and insulin sensitivity in obese IFN-gamma knockout mice. Metabolism 2012; 61: 1152-1161.
104. Wong N, Fam BC, Cempako GR et al. Deficiency in interferon-gamma results in reduced body weight and better glucose tolerance in mice. Endocrinology 2011; 152: 3690-3699.
105. Huebner L, Engeli S, Wrann CD, Goudeva L, Laue T, Kielstein H. Human NK cell subset functions are differentially affected by adipokines. PLoS One 2013; 8: e75703.
106. Winer DA, Winer S, Shen L et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011; 17: 610-U134.
107. Ji YW, Sun SY, Xu AM et al. Activation of natural killer T cells promotes M2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J Biol Chem 2012; 287: 13561-13571.
108. Mantell BS, Stefanovic-Racic M, Yang X, Dedousis N, Sipula IJ, O'Doherty RM. Mice lacking NKT cells but with a complete complement of CD8(+) T-cells are not protected against the metabolic abnormalities of diet-induced obesity. Plos One 2011; 6: e19831.
109. Ohmura K, Ishimori N, Ohmura Y et al. Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice. Arterioscler Thromb Vasc Biol 2010; 30: 193-199.
110. Satoh M, Andoh Y, Clingan CS et al. Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance. PLoS One 2012; 7: e30568.
111. Lynch L. Adipose invariant natural killer T cells. Immunology 2014; 142: 337-346.
112. Jahng A, Maricic I, Aguilera C, Cardell S, Halder RC, Kumar V. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med 2004; 199: 947-957.
113. Boes M, Stoppelenburg AJ, Sille FC. Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction. Immunology 2009; 127: 163-170.
114. Ji Y, Sun S, Xia S, Yang L, Li X, Qi L. Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. J Biol Chem 2012; 287: 24378-24386.
115. Lynch L, Nowak M, Varghese B et al. Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 2012; 37: 574-587.
116. Rakhshandehroo M, Kalkhoven E, Boes M. Invariant natural killer T cells in adipose tissue: novel regulators of immune-mediated metabolic disease. Cell Mol Life Sci 2013; 70: 4711-4727.
117. Kondo T, Toyoshima Y, Ishii Y, Kyuwa S. Natural killer T cells in adipose tissue are activated in lean mice. Exp Anim 2013; 62: 319-328.
118. Schipper HS, Prakken B, Kalkhoven E, Boes M. Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol Metab 2012; 23: 407-415.
119. Lynch L, O'Shea D, Winter DC, Geoghegan J, Doherty DG, O'Farrelly C. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur J Immunol 2009; 39: 1893-1901.
120. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004; 114: 1379-1388.
121. Wu L, Parekh VV, Gabriel CL et al. Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. Proc Natl Acad Sci U S A 2012; 109: E1143-E1152.
122. Florence WC, Bhat RK, Joyce S. CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences. Expert Rev Mol Med 2008; 10: e20.
123. Huh JY, Kim JI, Park YJ et al. A novel function of adipocytes in lipid antigen presentation to iNKT cells. Mol Cell Biol 2013; 33: 328-339.
124. Ilan Y, Maron R, Tukpah AM et al. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci U S A 2010; 107: 9765-9770.
125. Caspar-Bauguil S, Cousin B, Galinier A et al. Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett 2005; 579: 3487-3492.
126. Arrenberg P, Maricic I, Kumar V. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice. Gastroenterology 2011; 140: 646-655.
127. Caspar-Bauguil S, Cousin B, Bour S, Casteilla L, Penicaud L, Carpene C. Adipose tissue lymphocytes: types and roles (vol 65, pg 423, 2009). J Physiol Biochem 2011; 67: 497-497.
128. Winer S, Chan Y, Paltser G et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15: 921-929.
129. McLaughlin T, Liu LF, Lamendola C et al. T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler Thromb Vasc Biol 2014; 34: 2637-2643.
130. Rausch ME, Weisberg S, Vardhana P, Tortoriello DV. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes (Lond) 2008; 32: 451-463.
131. Feuerer M, Herrero L, Cipolletta D et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009; 15: 930-939.
132. Sun S, Ji Y, Kersten S, Qi L. Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr 2012; 32: 261-286.
133. Oestreich KJ, Weinmann AS. Master regulators or lineage-specifying? Changing views on CD4+ T cell transcription factors. Nat Rev Immunol 2012; 12: 799-804.
134. Oh DY, Morinaga H, Talukdar S, Bae EJ, Olefsky JM. Increased macrophage migration into adipose tissue in obese mice. Diabetes 2012; 61: 346-354.
135. Cipolletta D, Feuerer M, Li A et al. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012; 486: 549-553.
136. Zeyda M, Huber J, Prager G, Stulnig TM. Inflammation correlates with markers of T-cell subsets including regulatory t cells in adipose tissue from obese patients. Obesity 2011; 19: 743-748.
137. Goossens GH, Blaak EE, Theunissen R et al. Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans. Mol Immunol 2012; 50: 142-149.
138. Wu HZ, Ghosh S, Perrard XD et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007; 115: 1029-1038.
139. Zuniga LA, Shen WJ, Joyce-Shaikh B et al. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol 2010; 185: 6947-6959.
140. Haas KM, Poe JC, Steeber DA, Tedder TF. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005; 23: 7-18.
141. Dalmas E, Venteclef N, Caer C et al. T cell-derived IL-22 amplifies IL-1beta-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes 2014; 63: 1966-1977.
142. Fabbrini E, Cella M, McCartney SA et al. Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology 2013; 145: e361-e363.
143. Bertola A, Ciucci T, Rousseau D et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes 2012; 61: 2238-2247.
144. Deiuliis J, Shah Z, Shah N et al. Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS One 2011; 6: e16376.
145. Eller K, Kirsch A, Wolf AM et al. Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy. Diabetes 2011; 60: 2954-2962.
146. Hong EG, Ko HJ, Cho YR et al. Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes 2009; 58: 2525-2535.
147. Shaikh SR, Haas KM, Beck MA, Teague H. The effects of diet-induced obesity on B cell function. Clin Exp Immunol 2015; 179: 90-99.
148. Mauri C, Ehrenstein MR. The 'short' history of regulatory B cells. Trends Immunol 2008; 29: 34-40.
149. Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol 2008; 20: 332-338.
150. Carter NA, Vasconcellos R, Rosser EC et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J Immunol 2011; 186: 5569-5579.
151. Jagannathan M, McDonnell M, Liang Y et al. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 2010; 53: 1461-1471.
152. Winer DA, Winer S, Chng MH, Shen L, Engleman EG. B lymphocytes in obesity-related adipose tissue inflammation and insulin resistance. Cell Mol Life Sci 2014; 71: 1033-1043.
153. Kaminski DA, Randall TD. Adaptive immunity and adipose tissue biology. Trends Immunol 2010; 31: 384-390.
154. Deng T, Lyon CJ, Minze LJ et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab 2013; 17: 411-422.
155. DeFuria J, Belkina AC, Jagannathan-Bogdan M et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A 2013; 110: 5133-5138.
156. van Exel E, Gussekloo J, de Craen AJ et al. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-plus study. Diabetes 2002; 51: 1088-1092.
157. Nishimura S, Manabe I, Takaki S et al. Adipose natural regulatory b cells negatively control adipose tissue inflammation. Cell Metab 2013; 18: 759-766.
158. Kowalski GM, Nicholls HT, Risis S et al. Deficiency of haematopoietic-cell-derived IL-10 does not exacerbate high-fat-diet-induced inflammation or insulin resistance in mice. Diabetologia 2011; 54: 888-899.
159. Rangel-Moreno J, Moyron-Quiroz JE, Carragher DM et al. Omental milky spots develop in the absence of lymphoid tissue-inducer cells and support B and T cell responses to peritoneal antigens. Immunity 2009; 30: 731-743.
160. Moro K, Yamada T, Tanabe M et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010; 463: 540-544.
161. McDonnell ME, Ganley-Leal LM, Mehta A et al. B lymphocytes in human subcutaneous adipose crown-like structures. Obesity (Silver Spring) 2012; 20: 1372-1378.
162. Kanda H, Tateya S, Tamori Y et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006; 116: 1494-1505.
163. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 2007; 447: 1116-1120.
164. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Front Biosci 2008; 13: 453-461.